Recombinant Human Endostatin Endostar Inhibits Tumor Growth and Metastasis in a Mouse Xenograft Model of Colon Cancer

The Synergistic Effect of Recombinant Human Endostatin (YH-16) Combined with Oxaliplatin on Human Colorectal Carcinoma

(2013) D-W Zhang et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Endostatin inhibits tumour lymphangiogenesis and lymphatic metastasis via cell surface nucleolin on lymphangiogenic endothelial cells

(2010) Wei Zhuo et al.   JOURNAL OF PATHOLOGY

Cancer mortality in Europe, 2000–2004, and an overview of trends since 1975

(2009) C. La Vecchia et al.   ANNALS OF ONCOLOGY

Monoclonal Antibodies Targeting Vascular Endothelial Growth Factor

(2009) Jerry Y. Hsu et al.   BIODRUGS

Surgery with curative-intent in patients treated with first-line chemotherapy plus bevacizumab for metastatic colorectal cancer First BEAT and the randomised phase-III NO16966 trial

(2009) A Okines et al.   BRITISH JOURNAL OF CANCER

International Trends in Colorectal Cancer Incidence Rates

(2009) M. M. Center et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Cancer Statistics in Korea: Incidence, Mortality and Survival in 2005

(2009) Kyu-Won Jung et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Mechanisms of lymphatic metastasis in human colorectal adenocarcinoma

(2009) Daniel Royston et al.   JOURNAL OF PATHOLOGY

More is less—combining targeted therapies in metastatic colorectal cancer

(2009) Cornelis J. A. Punt et al.   Nature Reviews Clinical Oncology

Clinical Approaches Toward Tumor Angiogenesis: Past, Present and Future

(2008) Yasuyuki Fujita et al.   CURRENT PHARMACEUTICAL DESIGN

VEGF-D promotes tumor growth and lymphatic spread in a mouse model of hepatocellular carcinoma

(2008) Armin Thelen et al.   INTERNATIONAL JOURNAL OF CANCER